Fundraising Fox

Creative Medical Technology Holdings

NASDAQ: CELZ

Phoenix, US · Nevada corporation

Creative Medical Technology Holdings (CELZ) is a biotechnology company developing regenerative medicine and immunotherapy platforms for conditions in immunology, endocrinology, urogynecology, and orthopedics. Its technologies include autologous immunotherapy (ImmCelz), an allogenic cell platform (AlloStem), a cellular reprogramming platform (iPSCELZ), and rapid autologous therapy programs (StemSpine, OvaStem, CaverStem).

BiotechHealthtechMedical Devices

Founders & leadership

TWTimothy Warbington
Timothy WarbingtoninFounder · President - CEO
DDDonald Dickerson
Donald DickersoninExecutive
TI
Thomas IchimNamed on SEC filing

Board

AP
Amit PatelBoard director
AM
Annette MarleauBoard director

Reported raises · per SEC filings

Form D private placements

$22.5M disclosed across 16 of 17 rounds · 2016–2022

▶$17MraisedMay 2022 · 18 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Donald DickersonExecutive Officer, Director
  • Bruce S. UrdangDirector
  • Michael H. FingerDirector
  • Susan SnowDirector
  • Timothy WarbingtonExecutive Officer, Director
Offering amount
$17M
Amount sold
$17M
Sales commissions
$1.4M
Placement agents
Roth Capital Partners
First sale
May 2022
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.8MraisedAug 2021 · 17 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Timothy WarbingtonExecutive Officer, Director
  • Donald DickersonExecutive Officer, Director
  • Amit PatelDirector
  • Thomas IchimDirector
Offering amount
$4.5M
Amount sold
$3.8M
Sales commissions
$312.8K
Placement agents
Roth Capital Partners
First sale
Aug 2021
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$509KraisedSep 2018 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas IchimDirector
  • Timothy WarbingtonExecutive Officer, Director
  • Donald DickersonExecutive Officer, Director
  • Amit PatelDirector
Offering amount
$678.7K
Amount sold
$509K
First sale
Sep 2018
Incorporated
Corporation, Nevada
Federal exemptions
06b, 4a5
Full filing on SEC EDGAR ↗
▶$115KraisedMar 2018 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas IchimDirector
  • Amit PatelDirector
  • Timothy WarbingtonExecutive Officer, Director
  • Donald DickersonExecutive Officer, Director
Offering amount
$115K
Amount sold
$115K
Minimum investment
$115K
First sale
Mar 2018
Incorporated
Corporation, Nevada
Federal exemptions
06b, 4a5
Full filing on SEC EDGAR ↗
▶$27.5KraisedMar 2018 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Donald DickersonExecutive Officer, Director
  • Amit PatelDirector
  • Timothy WarbingtonExecutive Officer, Director
  • Thomas IchimDirector
Offering amount
$27.5K
Amount sold
$27.5K
Minimum investment
$27.5K
First sale
Feb 2018
Incorporated
Corporation, Nevada
Federal exemptions
06b, 4a5
Full filing on SEC EDGAR ↗
▶$44KraisedMar 2018 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas IchimDirector
  • Amit PatelDirector
  • Donald DickersonExecutive Officer, Director
  • Timothy WarbingtonExecutive Officer, Director
Offering amount
$44K
Amount sold
$44K
Minimum investment
$44K
First sale
Jan 2018
Incorporated
Corporation, Nevada
Federal exemptions
06b, 4a5
Full filing on SEC EDGAR ↗
▶$48KraisedMar 2018 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Timothy WarbingtonExecutive Officer, Director
  • Amit PatelDirector
  • Thomas IchimDirector
  • Donald DickersonExecutive Officer, Director
Offering amount
$48K
Amount sold
$48K
Minimum investment
$48K
First sale
Mar 2018
Incorporated
Corporation, Nevada
Federal exemptions
06b, 4a5
Full filing on SEC EDGAR ↗
▶$53KraisedMar 2018 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas IchimDirector
  • Donald DickersonExecutive Officer, Director
  • Timothy WarbingtonExecutive Officer, Director
  • Amit PatelDirector
Offering amount
$53K
Amount sold
$53K
Minimum investment
$53K
First sale
Feb 2018
Incorporated
Corporation, Nevada
Federal exemptions
06b, 4a5
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 4

by search overlap
Bioworld6 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Quiverquant4 shared keywordsQuiver Quantitative scrapes and aggregates alternative stock market data from across the internet into a free web dashboard. It targets retail investors, giving non-professional traders access to alternative data typically reserved for institutional money managers.
Cordicamedical4 shared keywordsCordica Medical provides design, development, and manufacturing services for medical device companies, covering product engineering, precision manufacturing, automated assembly, packaging, and supply chain management through FDA-registered and ISO 13485-certified facilities. It supports programs across therapeutic areas including interventional systems, drug delivery, wound care, and personal health, operating 19 facilities in the United States, Mexico, and Singapore.
Create4 shared keywordsCREATE Medicines is a clinical-stage biotech company that develops in vivo mRNA immune cell programming therapies. The company focuses on RNA therapeutics and immune engineering for cancer, autoimmune disease, and transplant rejection applications.

Companies competing with Creative Medical Technology Holdings for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Creative Medical Technology Holdings do?
Creative Medical Technology Holdings (CELZ) is a biotechnology company developing regenerative medicine and immunotherapy platforms for conditions in immunology, endocrinology, urogynecology, and orthopedics. Its technologies include autologous immunotherapy (ImmCelz), an allogenic cell platform (AlloStem), a cellular reprogramming platform (iPSCELZ), and rapid autologous therapy programs (StemSpine, OvaStem, CaverStem).
Who founded Creative Medical Technology Holdings?
Creative Medical Technology Holdings was founded by Timothy Warbington.
How much funding has Creative Medical Technology Holdings raised?
Creative Medical Technology Holdings has disclosed $22.5M raised across 16 of its 17 known rounds.
Where is Creative Medical Technology Holdings headquartered?
Creative Medical Technology Holdings is headquartered in Phoenix, US.